SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is centered on its Phase 3 melanoma cancer-vaccine results and anticipation of fuller ESMO data, reinforced by CEO comments positioning the company as an mRNA platform spanning oncology and other diseases. Bulls point to the pipeline and momentum, while skeptics question the treatments broader efficacy, commercial scalability and valuation.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys quarterly results beat expectations and management raised its full-year revenue outlook, with record growth in QNX drawing attention alongside discussion of new automotive and autonomous-driving design wins. Bulls see validation of the QNX growth story, while others question the muted share-price response and point to softer near-term guidance and weakness in Secure Communications.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtions reported achievement of 30 entangled logical qubits on its Sqale commercial quantum system, using 80 physical qubits, is driving attention as a significant quantum-computing milestone. Many traders view it as validation of the companys neutral-atom approach, while others say the stocks muted, choppy reaction and broader market conditions temper the excitement.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costcos fourth-quarter results beat expectations, but the shares barely moved as traders debated whether steady underlying comparable-sales growth can support the stocks premium valuation. The tariff-refund benefit drew scrutiny as a one-off earnings boost, while bulls pointed to resilient sales and bears questioned growth and valuation.

Akamai Technologies, Inc. is the cybersecurity and cloud computing company that powers and protects business online. The market security solutions, superior threat intelligence, and global operations team provide defense in depth to safeguard enterprise data and applications everywhere. The firm full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. The global enterprises trust Akamai to provide the industry reliability, scale, and expertise they need to grow their business with confidence. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamais large multi-year cloud infrastructure agreement with Anthropic to support AI workloads is driving attention, with traders viewing it as validation of Akamais AI-cloud opportunity. The bullish reaction is tempered by concerns about the capital spending required, potential warrant-related dilution, and profit-taking after the sharp initial rally.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektars breach-of-contract case with Eli Lilly over Rezpeg is dominating discussion, with traders reacting to reports of a roughly $90 million award while debating whether the result is a meaningful win or far below hoped-for damages. Conflicting claims about the verdict and uncertainty over its details are fueling volatile reactions and speculation about the litigations value to NKTR.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondos launch of onchain investment portfolios using BlackRock-developed strategies is driving attention, reinforcing the RWA-tokenization and institutional-adoption narrative. Traders are largely bullish on the development, while some question whether the ONDO token itself will benefit without a fee or other value-accrual mechanism; others are taking profits after the sharp move.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solars steep selloff and fresh lows are being tied to analyst downgrades and limited visibility into near-term bookings, alongside solar-policy uncertainty and higher-rate concerns. Traders disagree on whether the move is an overreaction and buying opportunity or a sign of further weakness; some instead speculate about short-selling or China-related news without confirmation.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus is drawing attention after managements positive Medicare reimbursement outlook for its cancer-testing products and improving revenue expectations, fueling a sharp rally. Traders are also discussing heavy short interest and bullish options flow as potential momentum amplifiers, while others warn the move may be extended and point to valuation and insider-selling concerns.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

FDA clearance of Lillys once-weekly basal insulin Onswik is drawing attention, with traders highlighting fewer injections for adults with type 2 diabetes and a new U.S. competitor to Novos weekly insulin. The reaction is broadly positive, though some discussion also focuses on Lillys broader GLP-1 competition and share-price momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
